The University of Michigan Health System
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pop-Busui, Rodica
SUGARNSALT, NCT06217302: Sotagliflozin to Slow Kidney Function Decline in Persons with Type 1 Diabetes and Diabetic Kidney Disease

Recruiting
3
150
Canada, US
Sotagliflozin, INPEFA, Placebo
Alessandro Doria, Canadian Institutes of Health Research (CIHR), The Kidney Foundation of Canada, The Cleveland Clinic, University of Michigan, University of Colorado, Denver, Northwestern University, Washington University School of Medicine, State University of New York - Upstate Medical University, Providence Medical Research Center, Stanford University, Montefiore Medical Center, University of Toronto, University Health Network, Toronto, University of Calgary, University of Alberta, University of British Columbia, Institut de Recherches Cliniques de Montreal, LMC Diabetes & Endocrinology Ltd., Joslin Diabetes Center, Lexicon Pharmaceuticals, DexCom, Inc., University of Washington, Breakthrough T1D
Diabetic Nephropathies, Kidney Failure, Chronic, Diabetes Mellitus Type 1, Heart Failure
12/28
05/29
TINSAL-T1DN, NCT02936843: Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy

Completed
2/3
61
US
Salsalate, disalcid, PLACEBO
University of Michigan
Type 1 Diabetes, Peripheral Neuropathy
05/23
05/23
PERL-FENO, NCT04929379: A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

Active, not recruiting
2
40
US
Fenofibrate, Placebo
Alessandro Doria, University of Michigan, University of Minnesota
Diabetic Nephropathies
05/25
08/25
NCT05169060: Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy

Recruiting
1/2
100
US
Fish Oil Concentrate, 1000 Mg Oral Capsule, Salsalate Oral Tablet
University of Iowa, University of Michigan
Diabetic Neuropathies
07/25
01/26
NCT05200819: Incidence and Predictors of Acute and Chronic Complications in Patients With Diabetes and Severe COVID-19

Completed
N/A
70
US
University of Michigan
Covid19, Diabetes Mellitus
02/23
02/23
NCT04591691: C-myc Biomarker Study for Diabetic Foot Ulcers

Completed
N/A
140
US
University of Michigan, Indiana University, Stanford University, University of Miami, University of Pittsburgh, University of California, San Francisco, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
07/23
07/23
NCT05328986: Kidney Disease After COVID-19

Active, not recruiting
N/A
3000
US
Icahn School of Medicine at Mount Sinai, New Jersey Medical School, University of Michigan, Yale New Haven Health System Center for Healthcare Solutions, Johns Hopkins University
COVID-19, Acute Kidney Injury, Chronic Kidney Injury
01/25
01/25
NCT02748018: Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home

Active, not recruiting
N/A
280
Europe, Canada, US, RoW
670G and 770G Insulin Pump, Subject's Current Diabetes Therapy
Medtronic Diabetes
Type 1 Diabetes
03/25
06/25
NCT06104969: DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Recruiting
N/A
5000
US
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetic Foot Ulcer, Diabetic Foot, Diabetes
06/28
06/28

Download Options